HomeCompareCHIZF vs JNJ

CHIZF vs JNJ: Dividend Comparison 2026

CHIZF yields 0.16% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHIZF wins by $7.4K in total portfolio value
10 years
CHIZF
CHIZF
● Live price
0.16%
Share price
$0.27
Annual div
$0.00
5Y div CAGR
79.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$8,388.25
Full CHIZF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — CHIZF vs JNJ

📍 CHIZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHIZFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHIZF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CHIZF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHIZF
Annual income on $10K today (after 15% tax)
$13.86/yr
After 10yr DRIP, annual income (after tax)
$7,130.01/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, CHIZF beats the other by $3,144.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHIZF + JNJ for your $10,000?

CHIZF: 50%JNJ: 50%
100% JNJ50/50100% CHIZF
Portfolio after 10yr
$34.0K
Annual income
$6,538.82/yr
Blended yield
19.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CHIZF
No analyst data
Altman Z
1.9
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHIZF buys
0
JNJ buys
0
No recent congressional trades found for CHIZF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHIZFJNJ
Forward yield0.16%2.13%
Annual dividend / share$0.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR79.4%28%
Portfolio after 10y$37.7K$30.3K
Annual income after 10y$8,388.25$4,689.40
Total dividends collected$16.7K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CHIZF vs JNJ ($10,000, DRIP)

YearCHIZF PortfolioCHIZF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,729$29.26$10,592$272.30+$137.00CHIZF
2$11,533$52.64$11,289$357.73+$244.00CHIZF
3$12,435$94.86$12,123$472.89+$312.00CHIZF
4$13,477$171.49$13,141$629.86+$336.00CHIZF
5$14,732$311.61$14,408$846.81+$324.00CHIZF
6$16,334$571.11$16,021$1,151.60+$313.00CHIZF
7$18,540$1,061.70$18,122$1,588.22+$418.00CHIZF
8$21,858$2,020.39$20,930$2,228.20+$928.00CHIZF
9$27,381$3,993.74$24,792$3,191.91+$2.6KCHIZF
10$37,686$8,388.25$30,274$4,689.40+$7.4KCHIZF

CHIZF vs JNJ: Complete Analysis 2026

CHIZFStock

China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of Chinese medicine and pharmaceutical products in the People's Republic of China. The company offers granules, finished drugs, decoction pieces, and healthcare products. It is also involved in the plantation and management of Chinese medicinal herbs; manufacturing of traditional Chinese medicines (TCM); trading of pharmaceutical products; provision of TCM marketing, advertising, and consulting services; and retail of pharmaceuticals and decoction products. The company also provides property leasing services. It sells its products to hospitals and retail pharmacies. The company was formerly known as China Traditional Chinese Medicine Co. Limited and changed its name to China Traditional Chinese Medicine Holdings Co. Limited in July 2016. China Traditional China Traditional Chinese Medicine Holdings Co. Limited was founded in 1573 and is headquartered in Wan Chai, Hong Kong.

Full CHIZF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CHIZF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHIZF vs SCHDCHIZF vs JEPICHIZF vs OCHIZF vs KOCHIZF vs MAINCHIZF vs ABBVCHIZF vs MRKCHIZF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.